Share Your Feedback

Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likely Extremely likely
(Optional)
MDT

Medtronic plc.

MDT Health technology
$127.7B
Market Cap

Shariah Analysis

Passed

Business Cash Liabilities

Based on AAOIFI screening standards, Medtronic plc. appears to be Passed.

Business Activity
FYE 2025
Non-Permissible Income (<5%) 1.50%
Non-Permissible
$511
Total Income
$34K
Revenue Breakdown
Cardiovascular
$12.5K
Neuroscience
$9.8K
Medical Surgical
$8.4K
Diabetes
$2.8K
Other operating segment net sales
$137
Other adjustments
-
Interest income
Non-Operating
$511
Non-Compliant: $511
Israel involvement

Israel Involvement

Total Funded
$748.1M
Employees in Israel
500+
Companies Funded
14
Overview

Medtronic Plc develops medical technology to alleviate pain, restore health, and extend life for millions of people around the world. The company operates in four segments: cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group.Medtronic Israel consists of four business divisions (Cardiovascular, Diabetes, Restorative and Minimal Invasive Technologies) and the Integrated Health Solution division, which provides innovative models and solutions for the health market. In recent years, Medtronic has acquired and invested in Israeli start-ups and technologies that manufacture and supply technologies and products around the world.The company also participates in the health incubatorMindUP, together with other companies. MindUP focuses on big data, predictive analytics, telemedicine, cloud computing, wearable and implantable sensors, advanced point-of-care diagnostics, and more.n recent years, Medtronic Global has acquired and invested in Israeli start-up and technology companies that manufacture and supply technologies and products around the world. Oridion Medical - developer of respiratory systems Given Imaging - which develops capsules for mapping the small and large intestines. Super Dimension - which develops a navigation system for endoscopic tools to treat lung diseases. Visionsense - which developed the first and only imaging system in the world that provides a 3D image using an endoscope in minimally invasive surgeries. Mazor Robotics - which develops a robotic system for navigating surgical tools in spine and brain surgeries. Nutrino - engaged in analyzing information and creating analytics in the field of nutrition

Israeli Portfolio
Itamar Medical
Itamar Medical

Home Sleep Testing and Endothelial Function Assessment

Raised: $190.45M 201-500
CathWorks
CathWorks

Noninvasive FFR Measurements for Coronary Interventions

Raised: $151.79M 51-200
BrainsGate
BrainsGate

Minimally Invasive Treatment for Central Nervous System Diseases

Raised: $98.5M 11-50
BioControl Medical
BioControl Medical

Active, Implantable Devices for Heart Failure

Raised: $70M 11-50
BlueWind Medical
BlueWind Medical

Neuromodulation Therapy for Urge Urinary Incontinence

Raised: $64M 51-200
BioProtect
BioProtect

Biodegradable Balloons for Safe Radiation Therapy

Raised: $62.25M 51-200
Mazor Robotics
Mazor Robotics

Robotic Platform for Spine Surgery

Raised: $50M 51-200
Triple Jump
Triple Jump

Insulin Pump for Patients with Diabetes

Raised: $20M 11-50
DreaMed Diabetes
DreaMed Diabetes

Personalized Diabetes Treatment Optimization Solutions

Raised: $16.8M 51-200
Odin Medical Technologies
Odin Medical Technologies

MRI Systems for Brain Surgery

Raised: $13M 1-10
Nutrino
Nutrino

Virtual Personal Nutritionist

Raised: $9.9M 11-50
CogMe
CogMe

A Holistic AI Platform for Preventing and Detecting Cognitive and Physiological Decline in Older Adults

Raised: $1.4M 1-10
AV Medical
AV Medical

Dialysis Access Management Balloon Catheter

11-50
VisionSense
VisionSense

Stereoscopic Sight for Minimally Invasive Surgery

0

Market Data

Exchange NYSE NYSE
Currency USD
Country United States
Last Updated 2025-12-31

Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.

Advertisement Banner